Universal Health (UHS)
NYSE:UHS
Want to see UHS full AI Analyst Report?
UHS Stock Chart & Stats
$182.41
$2.61(1.40%)
At close: 4:00 PM EST
$182.41
$2.61(1.40%)
Day’s Range― - ―
52-Week Range$152.33 - $246.33
Previous CloseN/A
Volume143.67K
Average Volume (3M)672.84K
Market Cap
$10.37B
Enterprise Value$15.65B
Total Cash (Recent Filing)$119.03M
Total Debt (Recent Filing)$5.13B
Price to Earnings (P/E)7.8
Beta0.54
Next Earnings
Jul 27, 2026EPS Estimate
5.79Next Dividend Ex-DateN/A
Dividend Yield0.35%
Share Statistics
EPS (TTM)24.14
Shares Outstanding53,780,983
10 Day Avg. Volume529,298
30 Day Avg. Volume672,843
Financial Highlights & Ratios
PEG Ratio0.26
Price to Book (P/B)1.91
Price to Sales (P/S)0.80
P/FCF Ratio16.32
Enterprise Value/Market Cap1.51
Enterprise Value/Revenue0.88
Enterprise Value/Gross Profit1.24
Enterprise Value/Ebitda5.60
Forecast
1Y Price Target
$225.92Price Target Upside23.85% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
EPS Forecast (FY)23.39
Revenue Forecast (FY)$18.53B
Bulls Say, Bears Say
Bulls Say
Acquisition And Virtual CareTalkspace acquisition is expected to be slightly accretive to adjusted earnings and enables a virtual intensive outpatient offering that can capture more post-discharge patients and expand the company's care continuum.
Behavioral Health StabilizationBehavioral-health patient days and admissions showed modest growth while staffing conditions improved, indicating potential stabilization and gradual recovery in that segment.
Capital Allocation And GuidanceManagement's profit guidance appears stronger than peers and share repurchases are expected to remain an active capital-allocation tool alongside the acquisition, supporting near-term shareholder returns.
Bears Say
Balance-sheet LeverageAcquisition financing increases financial leverage, which may constrain balance-sheet flexibility and limit the company's ability to pursue other strategic initiatives.
Payor Denials And Revenue RiskElevated payor denials are reducing revenue growth and introduce downside risk to revenue trends if denial rates do not improve.
Policy And Staffing HeadwindsExpiration of government subsidies combined with potential state behavioral-staffing requirements could reduce insured patient volumes and raise operating costs, creating meaningful headwinds for acute and behavioral results.
Universal Health News
UHS FAQ
What was Universal Health’s price range in the past 12 months?
Universal Health lowest stock price was $152.33 and its highest was $246.32 in the past 12 months.
What is Universal Health’s market cap?
Universal Health’s market cap is $10.37B.
When is Universal Health’s upcoming earnings report date?
Universal Health’s upcoming earnings report date is Jul 27, 2026 which is in 78 days.
How were Universal Health’s earnings last quarter?
Universal Health released its earnings results on Apr 27, 2026. The company reported $5.62 earnings per share for the quarter, beating the consensus estimate of $5.409 by $0.211.
Is Universal Health overvalued?
According to Wall Street analysts Universal Health’s price is currently Undervalued.
Does Universal Health pay dividends?
Universal Health pays a Quarterly dividend of $0.2 which represents an annual dividend yield of 0.35%. See more information on Universal Health dividends here
What is Universal Health’s EPS estimate?
Universal Health’s EPS estimate is 5.79.
How many shares outstanding does Universal Health have?
Universal Health has 53,780,983 shares outstanding.
What happened to Universal Health’s price movement after its last earnings report?
Universal Health reported an EPS of $5.62 in its last earnings report, beating expectations of $5.409. Following the earnings report the stock price went down -9.454%.
Which hedge fund is a major shareholder of Universal Health?
Currently, no hedge funds are holding shares in UHS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Universal Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$225.92 (23.85% Upside)
$225.92 (23.85% Upside)
Blogger Sentiment
Bullish
UHS Sentiment 63%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 237.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $128.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 4.3%
Last 30 Days ▼ 8.5%
Last 30 Days ▼ 8.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
4.76%
12-Months-Change
Fundamentals
Return on Equity
20.93%
Trailing 12-Months
Asset Growth
7.43%
Trailing 12-Months
Company Description
Universal Health
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. The company operates through Acute Care Hospital Services and Behavioral Health Care Services segments. Its hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services. As of February 24, 2022, it owned and/or operated 363 inpatient facilities, and 40 outpatient and other facilities located in 39 states; Washington, D.C.; the United Kingdom; and Puerto Rico. The company also provides commercial health insurance services; and various management services, which include central purchasing, information, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
UHS Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a largely positive operational and financial picture: solid top-line growth (revenue +9.6%), strong adjusted EBITDA and EPS growth, healthy operating cash flow, active share repurchases, and a strategically significant, expectedly accretive Talkspace acquisition that accelerates outpatient behavioral capabilities. Offsetting these positives were near-term volume headwinds driven by weaker flu season and winter weather, a meaningful and evolving HIX (exchange) headwind with conservatively reserved bad debt exposure (management reiterated a $75 million full-year impact), tougher prior-period supplemental payment comparisons that pressured core EBITDA in the quarter, and ongoing behavioral staffing/wage pressures and first-year losses at de novo hospitals. Overall, management reiterated guidance and emphasized expense discipline, margin initiatives (including AI), and M&A integration plans, and the balance of strong financial metrics and strategic actions outweighs the identified near-term headwinds.View all UHS earnings summariesUHS Net revenue Breakdown
9.61% Medicare
10.85% Managed Medicare
12.97% Medicaid
13.27% Managed Medicaid
25.89% Managed Care (HMO and PPOs)
5.07% UK Revenue
6.41% Other patient revenue and adjustments, net
7.08% Other non-patient revenue
UHS Stock 12 Month Forecast
Average Price Target
$225.92
▲(23.85% Upside)
Technical Analysis
Ownership Overview
5.94% Insiders
30.28% Mutual Funds
7.56% Other Institutional Investors
25.70% Public Companies and
Individual Investors